Gasoline RBOB (RB February 2027)/ XFTTRBNYMETH / NYMEX ETH
RB| 7/7/2025 12:00:00 AM | Chg. - | Bid5:35:00 PM | Ask5:34:48 PM | Open | High | Low | Previous Close |
|---|---|---|---|---|---|---|---|
| 1.8102USD | - | 1.7867 | 1.8398 | 1.8102 | 1.8102 | 1.8102 | 1.7999 |
GlobeNewswire
6/30
The Bouzy Group Announces Westin-Branded Residences Near Panama City, Offering New Investment Opport...
GlobeNewswire
6/24
LKQ Corporation and SYNETIQ, an IAA Company Announce Strategic European Joint Venture
GlobeNewswire
5/5
Regeneration Biomedical to Present Updated Phase 1 Trial Data on Autologous Stem Cell Therapy Inject...
GlobeNewswire
4/22
Zurab Tsereteli, Internationally Acclaimed Artist and Friend of Wolf Popper LLP, Dies at 91
GlobeNewswire
4/15
Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targe...
GlobeNewswire
4/1
REPEAT -- Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164...
GlobeNewswire
3/31
Radiance Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of RB-164™, an ROR-...
GlobeNewswire
2/24
Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the...
GlobeNewswire
2/19
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate
GlobeNewswire
2/18
Brunswick Exploration Announces 2025 Exploration Plans for Greenland and Stakes Additional Ground Ne...
GlobeNewswire
2/18
AMERICAN SALARS ACQUIRES 18,083 HECTARE BRAZIL HARDROCK LCT PEGMATITE PROPERTY WITH RECENT SAMPLING ...
GlobeNewswire
1/31
Axsome Therapeutics Hosts SYMBRAVO® FDA Approval Virtual Investor Event with Expert Thought Leader
